z-logo
open-access-imgOpen Access
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Author(s) -
Tadej Battelino,
Thomas Danne,
Richard M. Bergenstal,
Stephanie A. Amiel,
Roy W. Beck,
Torben Biester,
Emanuele Bosi,
Bruce A. Buckingham,
William T. Cefalu,
Kelly L. Close,
Claudio Cobelli,
Eyal Dassau,
J. Hans DeVries,
Kim C. Donaghue,
Klemen Dovč,
Francis J. Doyle,
Satish K. Garg,
George Grunberger,
Simon Heller,
Lutz Heinemann,
Irl B. Hirsch,
Roman Hovorka,
Weiping Jia,
Olga Kordonouri,
Boris Kovatchev,
Aaron J. Kowalski,
Lori M. Laffel,
Brian J. Levine,
Alexander Yur'evich Mayorov,
Chantal Mathieu,
Helen Murphy,
Revital Nimri,
Kirsten Nørgaard,
Christopher G. Parkin,
Éric Renard,
David Rodbard,
Banshi Saboo,
Desmond Schatz,
Keaton Stoner,
Tatsuiko Urakami,
Stuart A. Weinzimer,
Moshe Phillip
Publication year - 2019
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dci19-0028
Subject(s) - medicine , continuous glucose monitoring , interpretation (philosophy) , diabetes mellitus , consensus conference , intensive care medicine , medline , type 1 diabetes , endocrinology , computer science , programming language , political science , law
Improvements in sensor accuracy, greater convenience and ease of use, and expanding reimbursement have led to growing adoption of continuous glucose monitoring (CGM). However, successful utilization of CGM technology in routine clinical practice remains relatively low. This may be due in part to the lack of clear and agreed-upon glycemic targets that both diabetes teams and people with diabetes can work toward. Although unified recommendations for use of key CGM metrics have been established in three separate peer-reviewed articles, formal adoption by diabetes professional organizations and guidance in the practical application of these metrics in clinical practice have been lacking. In February 2019, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address this issue. This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom